Noema Pharma

BEYOND SYMPTOM CONTROL

Basel, Switzerland · Founded 2019 · $318.0M raised

Headquarters
Basel
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$318.0M
Last Round
$147.0M Extension RoundDec 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 7 investors for this company. The full record is or through the API.

About

Noema Pharma is a clinical-stage biotech company advancing a late-stage portfolio of oral small molecule therapeutics with well-characterized mechanisms for people living with neurological and related disorders. Founded in 2019 with a seed investment from Sofinnova Partners and four clinical-stage assets in-licensed from Roche, the company pursues both orphan and larger CNS indications — including vasomotor symptoms, Tourette syndrome, and other debilitating neurological conditions — for which there are significant unmet medical needs and compelling scientific rationales for superior clinical benefit.

Summary

Noema Pharma is a Biotech company based in Basel, Switzerland, founded in 2019. It has raised $318.0M in total across 4 rounds, most recently a $147.0M Extension Round in Dec 2024. Investors include Sofinnova Partners, EQT AB and Forbion Capital Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundDec 2024
$147.0M

Sign up to see all 4 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Noema Pharma on Indexed.vc
<a href="https://indexed.vc/companies/noema-pharma"><img src="https://indexed.vc/api/badge/company/noema-pharma" alt="Noema Pharma on Indexed.vc" width="260" height="76" /></a>